MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
종목 코드 MDXG
회사 이름MiMedx Group Inc
상장일Aug 20, 2007
CEOMr. Joseph H. (Joe) Capper
직원 수837
유형Ordinary Share
회계 연도 종료Aug 20
주소1775 W Oak Commons Court, Ne
도시MARIETTA
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호30062
전화17706519100
웹사이트https://mimedx.com/
종목 코드 MDXG
상장일Aug 20, 2007
CEOMr. Joseph H. (Joe) Capper
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음